KARL STORZ completed the acquisition of medical business of T1V.

KARL STORZ, a MedTech company, completed the acquisition of medical business of T1V, a US-based visual collaboration software company. Financial terms were not disclosed. “This strategic acquisition underscores our commitment to preparing for future opportunities to advance progress in digital surgery and shape the future of medicine. It ensures the future development of our CollaboratOR range, which enhances our ability to empower healthcare partners to excel daily, improving patients' lives globally.” The acquired T1V medical business will be fully integrated into KARL STORZ over the next 12 months, including all operations, research and development activities, sales support, and technical services. As part of the acquisition, a team of ten T1V employees relevant to the medical business will transition to KARL STORZ. Christy Gaudet, KARL STORZ’s Vice President Sales & Marketing Surgical & OR1 in the US, added: “Hundreds of successful CollaboratOR installations exemplify our dedication to innovation and digitalization. We are proud to offer a unique, best-in class integration solution, highlighted by CollaboratOR and strengthened by this acquisition,” Stefan Ort, KARL STORZ Chief Operating Officer.